InsidersTradesSigma
Follow the 한화플러스제4호기업인수목적 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 한화플러스제4호기업인수목적 has published 5 public disclosures. Market capitalisation: €42m. The latest transaction was reported on 8 October 2024 (Sale). Among the most active insiders: 케이비증권. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hanwha Plus No. 4 Special Purpose Acquisition Company is a special purpose acquisition company in the healthcare and pharmaceutical sector. It is listed on the XKRX market.